Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Showing 10 out of 24 products:
Novel sequence variants in SBF1 (c.1168C>G and c.2209_2210del) as the potential causative mutations in two siblings with severe axonal neuropathy, hearing loss, facial weakness and bulbar features.
ZNF195 (show ZNF195 Antibodies) and SBF1 are potential biomarkers for gemcitabine sensitivity in head and neck squamous cell carcinoma cell lines.
Compound heterozygous mutations in SBF1 appear to be the underlying causes of a novel Charcot-Marie-Tooth disease type 4B subtype (designated as CMT4B3) in a Korean family.
SBF1 (MTMR5) belongs to the myotubularin (show MTM1 Antibodies) family of phosphoinositides phosphatases-like
MTMR2 (show MTMR2 Antibodies) interacts with MTMR5 via its coiled-coil domain and that mutations in the coiled-coil domain of either MTMR2 (show MTMR2 Antibodies) or MTMR5 abrogate this interaction.
expressed at high levels in seminiferous tubules of the testis; mice that are nullizygous for Sbf1 exhibit male infertility characterized by azoospermia.
Probable pseudophosphatase. Lacks several amino acids in the catalytic pocket which renders it catalytically inactive as a phosphatase. The pocket is however sufficiently preserved to bind phosphorylated substrates, and maybe protect them from phosphatases. Inhibits myoblast differentiation in vitro and induces oncogenic transformation in fibroblasts.
DENN/MADD domain containing 7A
, SET-binding factor 1
, myotubularin related 5
, myotubularin-related protein 5